Showing results (721-730 of 774) with videos related to
Sort By:
Pageof 78
AIDS Research and Therapy|December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.Journal of Virology|February 4, 2021
Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In VivoAndrea Gramatica, Roland Schwarzer, William Brantley, et al.Nature Reviews. Immunology|July 21, 2012
Towards an HIV cure: a global scientific strategy, Steven G Deeks, Brigitte Autran, et al.The Journal of Infectious Diseases|August 8, 2018
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical StudiesGolnaz Namazi, Jesse M Fajnzylber, Evgenia Aga, et al.Nature|August 28, 2020
Distinct viral reservoirs in individuals with spontaneous control of HIV-1Chenyang Jiang, Xiaodong Lian, Ce Gao, et al.The Journal of Clinical Investigation|February 21, 2018
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1Maureen P Martin, Vivek Naranbhai, Patrick R Shea, et al.Nature Communications|August 28, 2024
Early biological markers of post-acute sequelae of SARS-CoV-2 infectionScott Lu, Michael J Peluso, David V Glidden, et al.Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19Michael J Peluso, Dylan Ryder, Robert Flavell, et al.Medrxiv : the Preprint Server for Health Sciences|May 25, 2021
A common allele of HLA mediates asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Tasneem Yusufali, Joseph J Sabatino, et al.The Lancet. HIV|February 26, 2026
Recommendations from the 2nd Consensus Workshop on Analytical Treatment Interruption in HIV Research TrialsThumbi Ndung'u, Krista L Dong, Donn J Colby, et al.Pageof 78